Skip to main content
. 2009 Jun 29;114(12):2393–2400. doi: 10.1182/blood-2009-03-211797

Figure 4.

Figure 4

Cumulative incidence of leukemic transformation, with death as a competing risk event. No statistically significant difference in time to transformation between these 2 groups of patients was demonstrated when the competing risk of death was included (P = .34, cumulative incidence analysis).